↓ Skip to main content

R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair

Overview of attention for article published in Molecular Cancer, August 2010
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
37 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair
Published in
Molecular Cancer, August 2010
DOI 10.1186/1476-4598-9-208
Pubmed ID
Authors

Mario Federico, Catherine E Symonds, Luigi Bagella, Flavio Rizzolio, Daniele Fanale, Antonio Russo, Antonio Giordano

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 19%
Student > Ph. D. Student 6 16%
Professor > Associate Professor 5 14%
Student > Doctoral Student 4 11%
Other 3 8%
Other 9 24%
Unknown 3 8%
Readers by discipline Count As %
Agricultural and Biological Sciences 13 35%
Medicine and Dentistry 8 22%
Biochemistry, Genetics and Molecular Biology 6 16%
Chemistry 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 1 3%
Unknown 6 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 December 2020.
All research outputs
#8,534,528
of 25,371,288 outputs
Outputs from Molecular Cancer
#692
of 1,918 outputs
Outputs of similar age
#38,007
of 104,055 outputs
Outputs of similar age from Molecular Cancer
#15
of 36 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,918 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,055 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.